Stonepine Capital Management, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Aprea Therapeutics, Inc. Common Stock (APRE)

Filing Manager
Stonepine Capital Management, LLC
Reporting Manager
Stonepine Capital Management, LLC
Security
Aprea Therapeutics, Inc. Common Stock
Symbol
APRE
Shares outstanding
5,615,588 shares
Disclosed Ownership
286,395 shares
Ownership
5.1%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 12:15:12 UTC
Date of event
31 Dec 2024
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Stonepine Capital Management, LLC 5.1% 286,395 0 286,395 /s/ Jon M. Plexico Managing Member
Stonepine Capital, L.P. 5.1% 286,395 0 286,395 /s/ Jon M. Plexico Managing Member of the General Partner, Stonepine GP, LLC
Stonepine GP, LLC 5.1% 286,395 0 286,395 /s/ Jon M. Plexico Managing Member
Jon M. Plexico 5.1% 286,395 0 286,395 /s/ Jon M. Plexico Reporting person